title: Complete resolution of life-threatening bleomycin-induced pneumonitis after treatment with imatinib mesylate in a patient with Hodgkin's lymphoma: hope for severe chemotherapy-induced toxicity?
authors.affiliation: Division of Medical Oncology, Institute for Cancer Research and Treatment, Turin, Italy. fabrizio.carnevale@ircc.it
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Carnevale-Schianca
authors.forename: Susanna
authors.initials: S
authors.lastname: Gallo
authors.forename: Delia
authors.initials: D
authors.lastname: Rota-Scalabrini
authors.forename: Dario
authors.initials: D
authors.lastname: Sangiolo
authors.forename: Marco
authors.initials: M
authors.lastname: Fizzotti
authors.forename: Daniela
authors.initials: D
authors.lastname: Caravelli
authors.forename: Antonio
authors.initials: A
authors.lastname: Capaldi
authors.forename: Giancarlo
authors.initials: G
authors.lastname: Anselmetti
authors.forename: Erica
authors.initials: E
authors.lastname: Palesandro
authors.forename: Lorenzo
authors.initials: L
authors.lastname: D'Ambrosio
authors.forename: Valentina
authors.initials: V
authors.lastname: Coha
authors.forename: Remo
authors.initials: R
authors.lastname: Obert
authors.forename: Massimo
authors.initials: M
authors.lastname: Aglietta
authors.forename: Giovanni
authors.initials: G
authors.lastname: Grignani
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001549:Benzamides; D001761:Bleomycin / Q000009:adverse effects*; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D011014:Pneumonia / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use*; D011859:Radiography
chemical_list: D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D001761:Bleomycin; D000068877:Imatinib Mesylate